What are minimal clinically important differences for patient-reported outcome measures after surgery for cervical spondylotic myelopathy? A 5-year Spine CORe™ analysis of QOD data
Neurosurgical Focus · 01.05.2026 · 60 (5) · E6
DOI: 10.3171/2025.12.focus25939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Focus, erschienen am 01.05.2026. Verfasst von Connor Berlin und 31 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, University of Virginia, Charlottesville, Virginia. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Minimal Clinically Important Difference, Spondylosis, Cervical Vertebrae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 148 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE The minimal clinically important difference (MCID) is widely used to interpret patient-reported outcome measures (PROMs) in cervical spondylotic myelopathy (CSM). However, consensus on its definition is lacking, and its long-term consistency remains unknown. The objective of this study was to determine if MCID thresholds for PROMs at 5 years after surgery for CSM remained consistent when compared to previously established 2-year values. METHODS The Spine CORe™ study group performed a post hoc analysis of the prospective Quality Outcomes Database. Eight established anchor- and distribution-based methods were applied to define MCID thresholds for the following PROMs: Neck Disability Index (NDI), neck pain numeric rating scale (NP-NRS), arm pain numeric rating scale (AP-NRS), 5-dimension EuroQol health utility questionnaire (EQ-5D) for quality-adjusted life years, and modified Japanese Orthopaedic Association (mJOA) scores. Predictive validity was evaluated using area under the curve (AUC) analysis with North American Spine Society satisfaction as the anchor, and results were compared with calculated 2-year values from the same cohort using DeLong’s test. RESULTS A total of 1085 patients were originally enrolled, with ≥ 80% follow-up for all PROMs except the mJOA score (79%). At 5 years, optimal percentage change and ≥ 30% improvement methods were consistently highest performing for the NDI (AUC 0.71 and 0.68, respectively), NP-NRS (AUC 0.65 for both), and AP-NRS (AUC 0.73 and 0.72, respectively) scores. For the EQ-5D score, both the optimal numeric cutoff and one-half standard deviation methods performed best, yielding a consistent MCID threshold of 0.11 (AUC 0.64 for both). For the mJOA score, the severity-adjusted method provided the strongest discrimination, with an AUC of 0.74 at 5 years. MCID thresholds were consistent between 2 and 5 years, except for the severity-adjusted MCID for the mJOA score (0.74 at 5 years vs 0.65 at 2 years, p = 0.026). The 30% improvement threshold corresponded to absolute changes of 11.3 points for the NDI score, 1.5 points for the NP-NRS score, and 1.4 points for the AP-NRS score based on mean baseline scores. CONCLUSIONS To the authors’ knowledge, this represents the largest cohort of patients with CSM in the United States with validated, long-term 5-year MCID thresholds. This study establishes practical MCID definitions for NDI (≥ 30% improvement threshold of 11.3 points), NP-NRS and AP-NRS (≥ 30% improvement thresholds of 1.5 and 1.4 points, respectively), EQ-5D (optimal numeric cutoff of 0.11), and mJOA (severity-adjusted: ≥ 3 points for severe, ≥ 2 for moderate, ≥ 1 for mild) scores that can serve as benchmarks for evaluating improvement after CSM surgery in both research and routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1Department of Neurosurgery, University of Virginia, Charlottesville, Virginia.
- 2Department of Neurological Surgery, University of Chicago, Chicago, Illinois.
- 3Department of Neurological Surgery, University of Tennessee Health Science Center, Semmes Murphey Clinic, Memphis, Tennessee.
- 4Department of Neurological Surgery, University of California, San Francisco, California.
- 5Department of Neurosurgery, Columbia University, New York, New York.
- 6Department of Neurological Surgery, Weill Cornell Medicine, New York, New York.
Zitieren
APA
Berlin, C., Delawan, M., Matache, I. M., Kabangu, J. K., Grogan, D., Garcia, G., Mummaneni, P. V., Chan, A. K., Chou, D., Fu, K. M., Bisson, E. F., Shaffrey, C. I., Gottfried, O. N., Asher, A. L., Kim, P., Coric, D., Potts, E. A., Alentado, V. J., Foley, K. T., …, & Park, P. (2026). What are minimal clinically important differences for patient-reported outcome measures after surgery for cervical spondylotic myelopathy? A 5-year Spine CORe™ analysis of QOD data. Neurosurgical Focus, 60(5), E6. https://doi.org/10.3171/2025.12.focus25939
Vancouver
Berlin C, Delawan M, Matache IM, Kabangu JK, Grogan D, Garcia G, et al. What are minimal clinically important differences for patient-reported outcome measures after surgery for cervical spondylotic myelopathy? A 5-year Spine CORe™ analysis of QOD data. Neurosurgical Focus. 2026;60(5):E6. doi:10.3171/2025.12.focus25939
BibTeX
@article{Berlin2026,
author = {Berlin, Connor and Delawan, Maliya and Matache, Irina-Mihaela and Kabangu, Jean-Luc K and Grogan, Dayton and Garcia, Gracie and Mummaneni, Praveen V and Chan, Andrew K and Chou, Dean and Fu, Kai-Ming and Bisson, Erica F and Shaffrey, Christopher I and Gottfried, Oren N and Asher, Anthony L and Kim, Paul and Coric, Domagoj and Potts, Eric A and Alentado, Vincent J and Foley, Kevin T and Wang, Michael Y and Virk, Michael S and Knightly, John J and Meyer, Scott and Upadhyaya, Cheerag D and Tumialán, Luis M and Turner, Jay D and Uribe, Juan and Haid, Regis W and Yee, Timothy J and Yen, Chun-Po and Bydon, Mohamad and Park, Paul},
title = {What are minimal clinically important differences for patient-reported outcome measures after surgery for cervical spondylotic myelopathy? A 5-year Spine CORe™ analysis of QOD data},
journal = {Neurosurgical Focus},
year = {2026},
volume = {60},
number = {5},
pages = {E6},
doi = {10.3171/2025.12.focus25939}
}
EUVIMED